Toll-like receptor agonists are they good adjuvants?

Keyphrases

• Antigen-presenting Cells 100%
• Toll-like 100%
• Tumor Antigen 100%
• Receptor Agonist 100%
• Patients with Cancer 50%
• Immune Response 50%
• T Cells 50%
• T Cell Activation 50%
• Antitumor Activity 50%
• Dendritic Cells 50%
• CD4+ T Cells 50%
• CD8+ T Cells 50%
• Adaptive Immunity 50%
• Immunization 50%
• Antigen Expression 50%
• Tumor-specific 50%
• Dendritic Cell Function 50%
• Immune Suppression 50%
• Antitumor Immune Response 50%
• Cancer Regression 50%
• Therapeutic Immunization 50%
• Novel Adjuvant 50%

Immunology and Microbiology

• Agonist 100%
• Adjuvant 100%
• Toll-Like Receptor 100%
• T Cell 66%
• Immune Response 66%
• Tumor Antigen 66%
• Antigen-Presenting Cell 66%
• T-Helper Cell 33%
• Antineoplastic Activity 33%
• Dendritic Cell 33%
• Cytotoxic T-Cell 33%
• Adaptive Immune System 33%
• Dendritic Cell Function 33%
• Antigen Expression 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Toll Like Receptor Agonist 100%
• Adjuvant 100%
• Malignant Neoplasm 66%
• Tumor Antigen 66%
• Neoplasm 33%
• Toll Like Receptor 33%
• Antitumor Activity 33%
• CD8 Antigen 33%
• Cancer Regression 33%